FTSE 100 Live: London stocks open higher as miners offset HSBC slide

London’s FTSE 100 opened higher, up about 30 points to around 10,888, with miners and defence stocks offsetting weakness in HSBC. HSBC reported profit growth and resumed buybacks, though analysts said the buyback was smaller than expected. Travis Perkins shares rose after interim results. Smith+Nephew cut full-year revenue growth guidance; BP reported sharply higher Q2 profits.

Original reporting
Published Aug 4, 2026, 9:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 9:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FTSE 100 Live: London stocks open higher as miners offset HSBC slide — source image
Decision brief

The 30-second read

$HSBCNeutralMed
01

Why it matters

Traders can act on near-term catalysts: guidance changes (SNN), earnings and cash-flow beats (BP), turnaround signals (TPK), and M&A final terms (SEGRO). For HSBC, the earnings beat is tempered by buyback size disappointment and explicit political windfall-tax pressure.

02

Market read

Index direction is supported by miners and defence, but stock-specific catalysts are mixed, especially guidance cuts and political tax risk for banks.

03

What to watch

Deal-spread dynamics for Segro depend on FX and US suitor share movements, and guidance cuts (Smith & Nephew) may already be partially priced given the magnitude of the prior move.

Relevance 6/10Novelty 5/10Timing: London open, with multiple same-morning catalysts and guidance/buyback details

Background

This is a London market open wrap that also includes several company-specific updates: HSBC buybacks and profit beat, Smith & Nephew guidance cut, BP profit surge, Travis Perkins turnaround progress, and a Segro takeover final-terms update.

Company-level read

Ticker impact

$HSBCNeutralMedium confidence
Context

HSBC resumed buybacks and approved a second dividend after profits beat estimates, but analysts flag a smaller-than-expected buyback and political windfall-tax risk.

Expected impact

Choppy trading risk, with downside skew if tax rhetoric intensifies and upside limited by buyback being modest versus expectations.

Evidence & confidence

The article cites a Q2 PBT beat, balance-sheet growth, and ROTE guidance, but also highlights buyback underwhelming versus expectations and explicit political pressure for higher bank taxes.

$SNNBearishHigh confidence
Context

Smith & Nephew cut full-year revenue growth guidance to around 4% from about 6% after weakness in US orthopaedics and wound care.

Expected impact

Further downside risk or continued underperformance versus peers until management provides clearer visibility on US segment recovery.

Evidence & confidence

The article states a concrete guidance reduction and links it to specific business weakness, which typically drives near-term estimate revisions.

$BPBullishMedium confidence
Context

BP reported second-quarter profits more than doubling, with underlying replacement cost profit rising to $5.7B and operating cash flow up 73% year on year.

Expected impact

Bullish bias for the stock on earnings quality and cash generation, though sensitivity to commodity prices remains.

Evidence & confidence

The article includes multiple hard datapoints (profit, operating cash flow, net debt reduction) but does not provide forward guidance, so conviction is limited to the reported quarter.

$AALBullishLow confidence
Context

Anglo American is cited as up about 2.7% in early trading as miners offset other weakness in the FTSE 100 open.

Expected impact

Tactical upside possible if commodity sentiment persists, but no durable catalyst is provided here.

Evidence & confidence

The article provides only an intraday move and sector framing, not a company-specific news item.

$BA.LBullishLow confidence
Context

BAE Systems is cited as up over 2% at the FTSE 100 open as defence stocks supported the index.

Expected impact

Tactical strength possible, but durability depends on broader risk-on and defence sentiment.

Evidence & confidence

Only early trading performance is provided, with no specific BAE Systems event described.

$AZNNeutralLow confidence
Context

AstraZeneca rebounded about 1.9% after yesterday’s big fall, with the article attributing the rebound to the prior index reshuffle.

Expected impact

Mean-reversion possible, but without new information the move may fade.

Evidence & confidence

The article references yesterday’s fall but does not disclose new AZN-specific facts today.

Market effects

Banking sentiment may be pressured by windfall-tax rhetoric, while miners and defence provide near-term index support.

UK-focused domestic earnings sensitivity is highlighted, with flows still weak and rates weighing on domestics.

Commodity-linked moves (miners) and global rates sensitivity (banks) can spill into broader European risk appetite.

Counterpoint

The windfall-tax narrative may be political noise; HSBC’s profitability and balance-sheet growth could matter more than buyback optics.

Key entities

  • HSBC

    Resumed buybacks and approved a second dividend after profits beat estimates, but buyback was modest and windfall-tax calls are rising.

  • Smith & Nephew

    Cut full-year revenue growth guidance to around 4% from about 6% due to weakness in US orthopaedics and wound care.

  • Travis Perkins

    Interim results show turnaround progress; revenue declined but price inflation returned and adjusted operating profit was flat ex property.

  • BP

    Second-quarter profits more than doubled, with higher underlying replacement cost profit and stronger operating cash flow.

  • Segro

    Agreed final terms for takeover by Prologis at a £13.5B valuation, adjusted lower versus the earlier figure due to FX and US share moves.

Related articles

$AZNMed

AstraZeneca Drug Extends Survival in Advanced Gastric Cancer

AstraZeneca reported Phase III CLARITY-Gastric01 results for sonesitatug vedotin, a CLDN18.2-targeted antibody-drug conjugate, in previously treated CLDN18.2-positive advanced gastric and related cancers. The trial met the primary overall-survival endpoint in third-line or later patients and a key secondary OS endpoint. PFS favored but was not significant; safety was consistent with prior profiles. Data will be submitted to regulators.

$AZNMedAI 8/10

AstraZeneca: Enhertu® Gains New Breast Cancer Indication Approval

AstraZeneca Pharma India said, according to its Aug. 7, 2026 statement, that India’s CDSCO approved permission to import and distribute Enhertu (trastuzumab deruxtecan) for an additional indication. The new label covers adjuvant treatment of adults with HER2-positive breast cancer and residual invasive disease after specified neoadjuvant therapy, enabling broader sales in India subject to further approvals.

$BXMedAI 8/10

Blackstone leads landmark USD25bn home loan portfolio buy

Blackstone-led consortium agreed to acquire HSBC’s Australian home loan portfolio for AUD36 billion (USD25 billion), according to Blackstone and law firms. Blackstone Credit & Insurance, Blackstone Tactical Opportunities, and Blackstone Real Estate Debt Strategies will finance the purchase, with Pepper Money as servicer. Completion depends on regulatory approvals.

$BPMed

BP buys out Woodside in Trinidad deepwater gas field

BP agreed to acquire Woodside Energy’s interest in the Calypso deepwater gas project in Trinidad and Tobago. BP will buy a 70% stake in Block TTDAA 14, raising its ownership to 100% and taking over operatorship. The deal is expected to close by end-2026. Woodside says Calypso has 3.5trn cu ft reserves.